15-Deoxy-Δ^12,14-prostaglandin J₂ prevents oxidative injury by upregulating the expression of aldose reductase in vascular smooth muscle cells

References

• Straus DS, Glass CK. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 2001;21:185–210.
   PubMed Web of Science ®Google Scholar
• Scher JU, Pillinger MH. 15d-PGJ2: the anti-inflammatory prostaglandin?Clin Immunol 2005;114:100–109.
   PubMed Web of Science ®Google Scholar
• Kansanen E, Kivelä AM, Levonen AL. Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12, 14-prostaglandin J2. Free Radic Biol Med 2009;47: 1310–1317.
   Google Scholar
• Shiraki T, Kamiya N, Shiki S, Kodama TS, Kakizuka A, Jingami H. Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma. J Biol Chem 2005;280: 14145–14153.
   PubMed Web of Science ®Google Scholar
• Kim EH, Surh YJ. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem Pharmacol 2006;72:1516–1528.
   PubMed Web of Science ®Google Scholar
• Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391:82–86.
   PubMed Web of Science ®Google Scholar
• Jackson SM, Parhami F, Xi XP, Berliner JA, Hsueh WA, Law RE, Demer LL. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte–endothelial cell interaction. Arterioscler Thromb Vasc Biol 1999;19:2094–2104.
   PubMed Web of Science ®Google Scholar
• Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, et al. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci U S A 2000;97:4844–4849.
   PubMed Web of Science ®Google Scholar
• Qin S, McLaughlin AP, De Vries GW. Protection of RPE cells from oxidative injury by 15-deoxy-delta12,14-prostaglandin J2 by augmenting GSH and activating MAPK. Invest Ophthalmol Vis Sci 2006;47:5098–5105.
   PubMedGoogle Scholar
• Abdo H, Mahé MM, Derkinderen P, Bach-Ngohou K, Neunlist M, Lardeux B. The omega-6 fatty acid derivative 15-deoxy-Δ12,14-prostaglandin J2 is involved in neuroprotection by enteric glial cells against oxidative stress. J Physiol 2012;590:2739–2750.
   Google Scholar
• Lim SY, Jang JH, Na HK, Lu SC, Rahman I, Surh YJ. 15-Deoxy-Delta12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis. J Biol Chem 2004; 279:46263–46270.
   PubMed Web of Science ®Google Scholar
• Levonen AL, Dickinson DA, Moellering DR, Mulcahy RT, Forman HJ, Darley-Usmar VM. Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathioneinduction and apoptosis in human endothelial cells. Arterioscler Thromb Vasc Biol 2001;21:1846–1851.
   PubMed Web of Science ®Google Scholar
• Lee TS, Tsai HL, Chau LY. Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12, 14-prostaglandin J2. J Biol Chem 2003;278:19325–19330.
   PubMed Web of Science ®Google Scholar
• Alvarez-Maqueda M, El Bekay R, Alba G, Monteseirín J, Chacón P, Vega A, et al. 15-deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes. J Biol Chem 2004;279:21929–21937.
   Google Scholar
• Zhang X, Lu L, Dixon C, Wilmer W, Song H, Chen X, Rovin BH. Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in human mesangial cells. Kidney Int 2004;65:798–810.
   Google Scholar
• Rittner HL, Hafner V, Klimiuk PA, Szweda LI, Goronzy JJ, Weyand CM. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest 1999;103:1007–1013.
   PubMed Web of Science ®Google Scholar
• Seo HG, Nishinaka T, Yabe-Nishimura C. Nitric oxide up-regulates aldose reductase expression in rat vascular smooth muscle cells: a potential role for aldose reductase in vascular remodeling. Mol Pharmacol 2000;57:709–717.
   PubMed Web of Science ®Google Scholar
• Chang KC, Paek KS, Kim HJ, Lee YS, Yabe-Nishimura C, Seo HG. Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Mol Pharmacol 2002;61:1184–1191.
   PubMed Web of Science ®Google Scholar
• Keightley JA, Shang L, Kinter M. Proteomic analysis of oxidative stress-resistant cells: a specific role for aldose reductase overexpression in cytoprotection. Mol Cell Proteomics 2004;3:167–175.
   PubMed Web of Science ®Google Scholar
• Kang ES, Woo IS, Kim HJ, Eun SY, Paek KS, Kim HJ, et al. Up-regulation of aldose reductase expression mediated by phosphatidylinositol 3-kinase/Akt and Nrf2 is involved in the protective effect of curcumin against oxidative damage. Free Radic Biol Med 2007;43:535–545.
   PubMed Web of Science ®Google Scholar
• Kang ES, Kim GH, Woo IS, Kim HJ, Eun SY, Ham SA, et al. Down-regulation of aldose reductase renders J774A.1 cells more susceptible to acrolein- or hydrogen peroxide-induced cell death. Free Radic Res 2008;42:930–938.
   Web of Science ®Google Scholar
• Kang ES, Iwata K, Ikami K, Ham SA, Kim HJ, Chang KC, et al. Aldose reductase in keratinocytes attenuates cellular apoptosis and senescence induced by UV radiation. Free Radic Biol Med 2011;50:680–688.
   PubMed Web of Science ®Google Scholar
• Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol Rev 1998;50:21–33.
   PubMed Web of Science ®Google Scholar
• Vander Jagt DL, Robinson B, Taylor KK, Hunsaker LA. Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications. J Biol Chem 1992;267:4364–4369.
   PubMed Web of Science ®Google Scholar
• Kolb NS, Hunsaker LA, Vander Jagt DL. Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity. Mol Pharmacol 1994;45:797–801.
   PubMed Web of Science ®Google Scholar
• Vander Jagt DL, Kolb NS, Vander Jagt TJ, Chino J, Martinez FJ, Hunsaker LA, Royer RE. Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate. Biochim Biophys Acta 1995; 1249:117–126.
   PubMed Web of Science ®Google Scholar
• Spycher SE, Tabataba-Vakili S, O’Donnell VB, Palomba L, Azzi A. Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells. FASEB J 1997;11:181–188.
   PubMed Web of Science ®Google Scholar
• Graham C, Szpirer C, Levan G, Carper D. Characterization of the aldose reductase-encoding gene family in rat. Gene 1991;107:259–267.
   Google Scholar
• Ruepp B, Bohren KM, Gabbay KH. Characterization of the osmotic response element of the human aldose reductase gene promoter. Proc Natl Acad Sci USA 1996;93:8624–8629.
   Google Scholar
• Li H, Nobukuni Y, Gui T, Yabe-Nishimura C. Characterization of genomic regions directing the cell-specific expression of the mouse aldose reductase gene. Biochem Biophys Res Commun 1999;255:759–764.
   Google Scholar
• Aida K, Tawata M, Ikegishi Y, Onaya T. Induction of rat aldose reductase gene transcription is mediated through the cis-element, osmotic response element (ORE): increased synthesis and/or activation by phosphorylation of ORE-binding protein is a key step. Endocrinology 1999;140:609–617.
   PubMed Web of Science ®Google Scholar
• Iwata T, Sato S, Jimenez J, McGowan M, Moroni M, Dey A, et al. Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-alpha. J Biol Chem 1999;274:7993–8001.
   Google Scholar
• Lee YS, Paek KS, Kang ES, Jang HS, Kim HJ, Kang YJ, et al. Involvement of nuclear factor kappaB in up-regulation of aldose reductase gene expression by 12-O-tetradecanoylphorbol-13-acetate in HeLa cells. Int J Biochem Cell Biol 2005;37:2297–2309.
   Google Scholar
• Gong P, Stewart D, Hu B, Li N, Cook J, Nel A, Alam J. Activation of the mouse heme oxygenase-1 gene by 15-deoxy-Delta(12,14)-prostaglandin J(2) is mediated by the stress response elements and transcription factor Nrf2. Antioxid Redox Signal 2002;4:249–257.
   PubMed Web of Science ®Google Scholar
• Itoh K, Mochizuki M, Ishii Y, Ishii T, Shibata T, Kawamoto Y, et al. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin J(2). Mol Cell Biol 2004;24:36–45.
   PubMed Web of Science ®Google Scholar
• Lim HJ, Lee KS, Lee S, Park JH, Choi HE, Go SH, et al. 15d-PGJ2 stimulates HO-1 expression through p38 MAP kinase and Nrf-2 pathway in rat vascular smooth muscle cells. Toxicol Appl Pharmacol 2007;223:20–27.
   PubMed Web of Science ®Google Scholar
• Nguyen T, Sherratt PJ, Pickett CB. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 2003;43:233–260.
   PubMed Web of Science ®Google Scholar
• Nishinaka T, Yabe-Nishimura C. EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress. Free Radic Biol Med 2001;31:205–216.
   PubMed Web of Science ®Google Scholar
• Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995;83:803–812.
   PubMed Web of Science ®Google Scholar
• Leesnitzer LM, Parks DJ, Bledsoe RK, Cobb JE, Collins JL, Consler TG, et al. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 2002;41:6640–6650.
   PubMed Web of Science ®Google Scholar
• Nishinaka T, Yabe-Nishimura C. Transcription factor Nrf2 regulates promoter activity of mouse aldose reductase (AKR1B3) gene. J Pharmacol Sci 2005;97:43–51.
   PubMed Web of Science ®Google Scholar
• Alam J, Stewart D, Touchard C, Boinapally S, Choi AM, Cook JL. Nrf2, a Cap’n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 1992; 274:26071–26078.
   Google Scholar
• Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999;13: 76–86.
   PubMed Web of Science ®Google Scholar
• Huang HC, Nguyen T, Pickett CB. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 2002; 277:42769–42774.
   PubMed Web of Science ®Google Scholar
• Li PF, Dietz R, Von Harsdorf R. Reactive oxygen species induce apoptosis of vascular smooth muscle cell. FEBS Lett 1997;404:249–252.
   PubMedGoogle Scholar
• Adler V, Yin Z, Tew KD, Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 1999;18:6104–6111.
   PubMed Web of Science ®Google Scholar
• Wang F, Tian F, Whitman SA, Zhang DD, Nishinaka T, Zhang N, Jiang T. Regulation of transforming growth factor β1-dependent aldose reductase expression by the Nrf2 signal pathway in human mesangial cells. Eur J Cell Biol 2012;91: 774–781.
   Google Scholar
• Bresson E, Lacroix-Pépin N, Boucher-Kovalik S, Chapdelaine P, Fortier MA. The prostaglandin F synthase activity of the human aldose reductase AKR1B1 brings new lenses to look at pathologic conditions. Front Pharmacol 2012;3:98.
   Google Scholar
• Kang ES, Kim GH, Kim HJ, Woo IS, Ham SA, Jin H, et al. Nrf2 regulates curcumin-induced aldose reductase expression indirectly via nuclear factor-kappaB. Pharmacol Res 2008; 58:15–21.
   PubMed Web of Science ®Google Scholar
• Kang KW, Cho IJ, Lee CH, Kim SG. Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz. J Natl Cancer Inst 2003;95: 53–66.
   PubMed Web of Science ®Google Scholar
• Martin D, Rojo AI, Salinas M, Diaz R, Gallardo G, Alam J, et al. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem 2004;279:8919–8929.
   PubMed Web of Science ®Google Scholar
• Hsu DK, Guo Y, Peifley KA, Winkles JA. Differential control of murine aldose reductase and fibroblast growth factor (FGF)-regulated-1 gene expression in NIH 3T3 cells by FGF-1 treatment and hyperosmotic stress. Biochem J 1997; 328:593–598.
   Google Scholar
• Ko BC, Ruepp B, Bohren KM, Gabbay KH, Chung SS. Identification and characterization of multiple osmotic response sequences in the human aldose reductase gene. J Biol Chem 1997;272:16431–16437.
   PubMed Web of Science ®Google Scholar